Ann: Ryoncil Pricing Set and Available This Quarter, page-212

First 212 Last

Share
Profile

Follow
GRolla247

254 Posts.

14

27/02/25

15:00

Post #: 78057474
Share

Originally posted by Pooslice: ↑

the fact there is that opportunity for a 'spurious correlation' is concerning. and entirely a function of not knowing the MoA.

We're not talking about paracetemol here. we're no talking about a bit of a headache and we don't know the MoA but hey, it's $2 and t works. We're talking about 1.5 million dollar treatments. And if you think for one second the insurance industry isn't going to do absolutely eveyrthing it can to get out of honouring it's commitments because its going to cost their shareholders dearly.... you have some serious thinking to do. Ryoncil is going to cost them over $100 000 000 every single year for treatments that don't work.

They will use the MoA argument. They will use the Japan experience argument. They will probably find out who among the senior exec pushed their dog around like a wheelbarrow when they were kids.

SrGVHD in kids is costing insurance $900 million right now. and that's going to increase to $1 500 000 000, That's $1.5 billion, if MSB has its way. Not to mention that's going to be $400 000 000 on failed treatments. where the child passes anyway.

I have no agenda. I live in a world of cold facts and reality. Insurance companies are unethical.

If MSB works out a way to reduce costs, that will all change.

Expand

Think you will find that MSB and Ryoncil treatments will reduce the overall (current not working) costs of treatment of SR AGVHD

MSB Price at posting: $2.51 Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

First 212 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.62		Change 0.010(0.62%)		Mkt cap ! $2.070B

Open	High	Low	Value	Volume
$1.60	$1.66	$1.60	$6.344M	3.894M

Buyers (Bids)

No.	Vol.	Price($)
2	102178	$1.62

Sellers (Offers)

Price($)	Vol.	No.
$1.63	52607	2

View Market Depth

No.	Vol.	Price($)
2	102178	1.620
4	72690	1.615
4	62248	1.610
3	26172	1.605
9	64387	1.600

Price($)	Vol.	No.
1.625	52607	2
1.630	12693	2
1.635	26000	2
1.640	48772	3
1.645	23972	2

Last trade - 16.12pm 26/06/2025 (20 minute delay)

MSB (ASX) Chart

Ann: Ryoncil Pricing Set and Available This Quarter, page-212

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Ryoncil Pricing Set and Available This Quarter, page-212

Top Stories

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

'Not possible' to port renewable gas: ACCC takes AGN to court

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News